In this research we propose a nanoplatform for anticancer therapy that is based on the combination of three components: 1) an antibiotic to target selectively the mitochondria of cancer cells, inhibiting their functions; 2) mineral nanoparticles (NPs) able to encapsulate the antibiotic and to enter into the cells across the cell membrane; and 3) a biocoating to protect the antibiotic during and/or after its regulated release, increasing its therapeutic efficacy. Chloramphenicol (CAM), a prototypical wide-spectrum antibiotic, has been used to induce mitochondrial-dysfunctions in cancer cells. Different in situ synthetic strategies have been tested to load such antibiotic into both crystalline hydroxyapatite (cHAp) and amorphous calcium phosphate (ACP) NPs. cHAp NPs showed higher loading capacity, in terms of encapsulation and superficial adsorption of CAM, and slower antibiotic release than ACP NPs. On the other hand, the protecting role played by biocoatings based on pyrophosphate and, especially, triphosphate was greater than biophosphonates, the anticancer therapeutic efficacy of CAM being maximized by the formers. In vitro studies using healthy and cancer cell lines have demonstrated that in situ CAM-loaded cHAp NPs coated with triphosphate selectively kill a great population of cancer cells, evidencing the potential of this nanoplatform in cancer treatment.
INTRODUCTION
derivatives 27 ). HAp-based platforms have been used for bone regeneration through adsorbing inorganic polyphosphates from the metabolism onto the mineral, [28] [29] [30] [31] for the fight against different bone diseases (e.g. osteoporosis, Paget disease of bone and malignancies metastatic to bone) through the delivery of biophosphonates as pharmacological agents, 32, 33 and for gene delivery by transfecting cells, as HAp is able to adsorb, transport and deliver nucleic acids inside the cell nucleus.
24, 34, 35 The current study focuses on antitumoral nanoplatforms that combine the ability of 
RESULTS AND DISCUSSION

Chloramphenicol-loaded hydroxyapatite: Preparation and characterization
Because of their different characteristics and properties, both crystalline HAp (cHAp) and amorphous calcium phosphate (ACP) NPs have been considered for this study. The experimental conditions used to prepare unloaded cHAp and ACP NPs 24, 27 were adapted for the in situ loading of CAM. In both cases a 0.5 M (NH 4 ) 2 HPO 4 aqueous solution was added drop-wise and under agitation to a 0.5 M Ca(NO 3 ) 2 ethanol solution, reagents being adjusted to get a Ca/P ratio of 1.67. The resultant suspension was aged for 24 h at 37 ºC to produce ACP, whereas cHAp was obtained by applying hydrothermal conditions during 24 h. Details of the experimental conditions and procedures are provided in the Supporting Information.
CAM-loaded NPs were prepared using four different in situ loading strategies: 2 minerals (cHAp or ACP)  2 loading paths of the antibiotic into the corresponding around 278 nm. 36 The intensity of the peaks increased gradually with the CAM concentration enabling calibration in a linear model ( Figure S1 ).
The sensitivity of the CAM distribution to the path is reflected in Figure 1b , which represents the weight ratio of adsorbed and encapsulated antibiotic with respect to the dry weight of mineral. The amount of CAM loaded through the Ca-path was greater than through the Pho-path for both cHAp and ACP. This difference mainly arises from the encapsulated antibiotic since the concentration of adsorbed CAM is similar for both ACP and cHAp NPs. This feature is consistent with the similar surface areas found for both kind of NPs. 24 Accordingly, hereafter discussion of the results have been mainly focused on CAM(Ca)-loaded cHAp and ACP NPs.
Control NPs, denoted CAM(c)/cHAp and CAM(c)/ACP, were prepared using an ex situ loading approach: deposition of 500 L of 150 mM CAM solution onto 50 mg of already synthetized cHAp and ACP NPs, respectively. The distribution of the accumulated antibiotic was completely different from those found for in situ loaded NPs ( Figure S2 ): the amount of CAM that penetrated into the mineral matrix for encapsulation was significantly smaller than the antibiotic adsorbed on the surface. In previous work we described the ability of both ACP and cHAp to adsorb biophosphates (e.g. pyrophosphates and triphosphates, abbreviated Table S1 ) confirmed the presence of the biocoating and its negligible influence in the internal structure of CAM-loaded mineral samples.
Effect of the loading in the bioactivity of CAM
The alicyclic form of CAM has been associated to its antimicrobial action. 40 In this bioactive conformation the hydroxyl groups of the antibiotic are engaged in closing an alicyclic ring by hydrogen bonding (Scheme 2). Accordingly, the activity of CAM could be altered by structural changes that affect the functional character of such hydroxyl groups. In this sub-section, we examine the effect of CAM···mineral interactions in the bioactive response of the antibiotic. 
CAM-Release in PBS and cell culture media
Quantitative release assays in the simplest physiological medium, PBS, were performed with CAM(Ca)/cHAp and CAM(Ca)/ACP NPs, CAM(c)/cHAp and CAM(c)/ACP NPs being used as controls. Results displayed in Figure 6a indicate that, although the amount of loaded antibiotic was entirely released after 72 h in all cases, the release rate was slower for CAM(Ca)/cHAp than for CAM(Ca)/ACP. More specifically, the time necessary to release 50% of loaded CAM (t 50 ) was 23 and 7 h respectively. On the other hand, the release rate was significantly faster for control NPs than for minerals loaded using the in situ approach 
Can CAM-loaded mineral NPs be used to fight cancer cells?
In previous sub-sections, we proved that cHAp and ACP NPs prepared using the in situ Ca-path are efficient platforms for the loading of bioactive CAM and its delayed release with respect to platforms prepared using the usual ex situ incubation approach.
In this section, we examine the response of cells to CAM(Ca)/cHAp and CAM(Ca)/ACP NPs. Initially, an exploratory study was conducted using the electroporation technique to facilitate the permeation of CAM-loaded mineral NPs across cell membranes, since the anticancer therapy using antibiotics is based on the targeting of mitochondria. [15] [16] [17] [18] Electroporation is the increment of the cell membrane permeability by exposing the cells to short electric current pulses from an external source. Such increase in permeability, which is related with the formation of nanoscale defects or pores in the cell membrane, allows the direct physical transfer of numerous kinds of chemical species into cells. In our case, we use this effect to ensure the entry of the NPs into the cells. 
Proving the antitumor efficacy of CAM-loaded mineral nanoparticles via endocytic pathway
The last aspect to be addressed in this work refers to the cellular uptake of biocoated CAM(Ca)/cHAp NPs from the surrounding fluid without artificially created transient pores at the cell membrane (i.e. without apply electroporation). Endocytosis is the form of active transport used by almost all living eukaryotic cells to internalize extracellular materials that cannot pass through the membrane by simple diffusion. It is known that
HAp enters into cells through the endocytic pathway. [42] [43] [44] As the endocytosis activity of cancer cells is greater than that of normal cells, [45] [46] [47] in this section we focus on the effect of both the biocoating and the loaded antibiotic in the efficiency of the endocytic process, which is expected to be closely related with the antitumor efficacy of the proposed therapeutic platforms. 
